Vukasin Paunovich compensation by year
American Well Summary Compensation Table · all 2 fiscal years held| Component | FY2022 | FY2023 |
|---|---|---|
| Salary | $231,477 | $485,000 |
| Bonus | $0 | $0 |
| Stock awards | $8,059,435 | $1,657,243 |
| Option awards | $0 | $0 |
| Non-equity incentive | $409,340 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $938 | $58,249 |
| Total | $8,701,190 | $2,200,492 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: American Well Corp DEF 14A filed April 26, 2024, accession 0000950170-24-049062, and prior-year filings. Open the filing on EDGAR.
How this page was built: the American Well Corp filed document, accession 0000950170-24-049062. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 1,689,798 | $2,517,799 | — |
| PSU | 411,567 | $613,235 | — |
| RSU | 274,378 | $408,823 | — |
| RSU | 112,653 | $167,853 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in American Well Corp's FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2023 proxy (filed April 26, 2024)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-01-02 | Sale | — | 444 | $7.17 | 116,121 |
| 2024-12-02 | Sale | — | 3,213 | $9.22 | 116,565 |
| 2024-10-01 | Sale | — | 398 | $9.15 | 119,778 |
| 2024-09-03 | Sale | — | 3,141 | $7.87 | 120,176 |
| 2024-07-01 | Sale | — | 7,956 | $0.30 | 2,461,133 |
| 2024-06-03 | Sale | — | 62,810 | $0.41 | 2,469,089 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
American Well’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Kathy Weiler | Executive Vice President, Chief Commercial and Growth Officer | $5,678,769 |
| Phyllis Gotlib | President, American Well International | $2,294,259 |
| Vukasin Paunovich · this page | EVP Enterprise Platforms | $2,200,492 |
| Robert Shepardson | Chief Financial Officer | $2,153,043 |
| Kurt Knight | Former Chief Operating Officer | $2,152,143 |
| Ido Schoenberg | Chairman & Chief Executive Officer | $797,800 |
| Roy Schoenberg | Executive Vice Chairman, Former co-Chief Executive Officer | $658,400 |
The full American Well compensation record
free company briefThis page is one person within American Well's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the American Well proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are American Well's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.